356P Efficacy and safety analysis of anlotinib and durvalumab plus chemotherapy in first-line therapy extensive-stage small cell lung cancer (SCLC)
Annals of Oncology（2022）
关键词
small cell lung cancer,cell lung cancer,lung cancer,chemotherapy,durvalumab,first-line,extensive-stage
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要